Prolaject B12 1000 For the treatment and control of cobalt deficiency in sheep and cattle
NAD+ Clinical Evidence Context Most published human RCT evidence on NAD+ uses oral precursors (NR and NMN), not direct injectable NAD+
This is clinically relevant because obesity itself is associated with numerous health conditions that might influence treatment tolerance, including metabolic syndrome, cardiovascular disease, sleep apnea, and hepatic steatosis
Factors like stomach acid levels, medication interactions, and digestive health all affect oral B12 absorption
[DOI] [PubMed] [Google Scholar] 209.Zhao G, Souers AJ, Voorbach M, et al
Recombinant GH (rGH) increases lean mass and lumbar spine bone density but, in healthy older adults, may raise the risk of diabetes, cancer, and fluid retention without improving muscle strength or physical performance [156]